keyword
https://read.qxmd.com/read/38011490/jak2v617f-mutation-and-associated-chromosomal-alterations-in-primary-and-secondary-myelofibrosis-and-post-hct-outcomes
#61
JOURNAL ARTICLE
Maryam Rafati, Derek Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadalla
JAK2V617F is the most common driver mutation in primary or secondary myelofibrosis in which allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment. Knowledge of the prognostic utility of JAK2 alterations in the HCT setting is limited. We identified all patients with MF who received HCT between 2000 and 2016 and had a pre-HCT blood sample (N=973) available at the Center of International Blood and Marrow Transplant Research biorepository. PacBio sequencing and SNP-array genotyping were used to identify JAK2V617F mutation and associated mosaic chromosomal alterations (mCAs), respectively...
October 27, 2023: Blood Advances
https://read.qxmd.com/read/38002003/differential-expression-of-microrna-mir-27-mir-145-among-dental-pulp-stem-cells-dpscs-following-neurogenic-differentiation-stimuli
#62
JOURNAL ARTICLE
Charlton Bassett, Hunter Triplett, Keegan Lott, Katherine M Howard, Karl Kingsley
This study sought to evaluate the expression of previously identified microRNAs known to regulate neuronal differentiation in mesenchymal stem cells (MSCs), including miR-27, miR-125, miR-128, miR-135, miR-140, miR-145, miR-218 and miR-410, among dental pulp stem cells (DPSCs) under conditions demonstrated to induce neuronal differentiation. Using an approved protocol, n = 12 DPSCs were identified from an existing biorepository and treated with basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF), which were previously demonstrated to induce neural differentiation markers including Sox1, Pax6 and NFM among these DPSCs...
November 9, 2023: Biomedicines
https://read.qxmd.com/read/37997023/military-exposures-and-gulf-war-illness-in-veterans-with-and-without-posttraumatic-stress-disorder
#63
JOURNAL ARTICLE
Stephen H Boyle, Julie Upchurch, Elizabeth J Gifford, Thomas S Redding, Elizabeth R Hauser, Deeksha Malhotra, Ashlyn Press, Kellie J Sims, Christina D Williams
Gulf War illness (GWI) is a chronic multisymptom disorder of unknown etiology that is believed to be caused by neurotoxicant exposure experienced during deployment to the Gulf War. Posttraumatic stress disorder (PTSD) covaries with GWI and is believed to play a role in GWI symptoms. The present study examined the association between self-reported military exposures and GWI, stratified by PTSD status, in veterans from the Gulf War Era Cohort and Biorepository who were deployed to the Persian Gulf during the war...
November 23, 2023: Journal of Traumatic Stress
https://read.qxmd.com/read/37993052/exposure-to-ambient-air-toxicants-and-the-risk-of-amyotrophic-lateral-sclerosis-als-a-matched-case-control-study
#64
JOURNAL ARTICLE
Fan Wu, Angela M Malek, Jeanine M Buchanich, Vincent C Arena, Judith R Rager, Ravi K Sharma, John E Vena, Todd Bear, Evelyn O Talbott
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with few risk factors identified and no known cure. Gene-environment interaction is hypothesized especially for sporadic ALS cases (90-95%) which are of unknown etiology. We aimed to investigate risk factors for ALS including exposure to ambient air toxics. METHODS: This population-based case-control study included 267 ALS cases (from the United States [U.S.] Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry National ALS Registry and Biorepository) and 267 age, sex, and county-matched controls identified via a commercial database...
November 20, 2023: Environmental Research
https://read.qxmd.com/read/37947484/association-of-active-renin-content-with-mortality-in-critically-ill-patients-a-post-hoc-analysis-of-the-vitamin-c-thiamine-and-steroids-in-sepsis-victas-trial
#65
JOURNAL ARTICLE
Laurence W Busse, Christopher L Schaich, Mark C Chappell, Michael T McCurdy, Erin M Staples, Caitlin C Ten Lohuis, Jeremiah S Hinson, Jonathan E Sevransky, Richard E Rothman, David W Wright, Greg S Martin, Ashish K Khanna
OBJECTIVE: Sepsis is a leading cause of mortality. Predicting outcomes is challenging and few biomarkers perform well. Defects in the renin-angiotensin system (RAS) can predict clinical outcomes in sepsis and may outperform traditional biomarkers. We postulated that RAS dysfunction (elevated active renin, angiotensin 1-7 [Ang-(1-7)], and angiotensin-converting enzyme 2 (ACE2) activity with depressed Ang-II and ACE activity) would be associated with mortality in a cohort of septic patients...
March 1, 2024: Critical Care Medicine
https://read.qxmd.com/read/37943607/improved-biorepository-to-support-sickle-cell-disease-genomics-and-clinical-research-a-practical-approach-to-link-patient-data-and-biospecimens-from-muhimbili-sickle-cell-program-tanzania
#66
JOURNAL ARTICLE
Upendo Masamu, Raphael Z Sangeda, Josephine Mgaya, Siana Nkya, Beatrice Octavian, Frank R Mtiiye, Joyce Nduguru, Agnes Jonathan, Daniel Kandonga, Irene K Minja, Paschal Rugajo, Emmanuel Balandya, Julie Makani
In Africa, sickle cell disease phenotypes' genetic contributors remain understudied due to the dearth of databases that pair biospecimens with demographic and clinical details. The absence of biorepositories in these settings can exacerbate this issue. This article documents the physical verification process of biospecimens in the biorepository, connecting them to patient clinical and demographic data and aiding in the planning of future genomic and clinical research studies' experience from the Muhimbili Sickle Cell Program in Dar es Salaam, Tanzania...
November 9, 2023: Biopreservation and Biobanking
https://read.qxmd.com/read/37932809/building-blocks-for-better-biorepositories-in-africa
#67
JOURNAL ARTICLE
Talishiea Croxton, Emmanuel Jonathan, Kareemah Suleiman, Olasinbo Balogun, Petronilla J Ozumba, Sharley M Aloyo, Gideon Nsubuga, Rogers E Kamulegeya, Lwanga Newton, John Mukisa, Mukthar Kader, Vuyo Damaneite, Sunji Nadoma, Ezenwa James Onyemata, Abbas Abel Anzaku, Emmanuel Nasinghe, Jennifer Troyer, Bonnie R Joubert, Christine Beiswanger, Moses L Joloba, Elizabeth Mayne, Alash'le Abimiku
BACKGROUND: Biorepositories archive and distribute well-characterized biospecimens for research to support the development of medical diagnostics and therapeutics. Knowledge of biobanking and associated practices is incomplete in low- and middle-income countries where disease burden is disproportionately high. In 2011, the African Society of Human Genetics (AfSHG), the National Institutes of Health (NIH), and the Wellcome Trust founded the Human Heredity and Health in Africa (H3Africa) consortium to promote genomic research in Africa and established a network of three biorepositories regionally located in East, West, and Southern Africa to support biomedical research...
November 6, 2023: Genome Medicine
https://read.qxmd.com/read/37883726/biospecimen-repositories-in-low-and-middle-income-countries-insights-from-an-american-university-of-beirut-and-memorial-sloan-kettering-collaboration
#68
JOURNAL ARTICLE
Walid Faraj, Mark Robson, Ayman Tawil, Victor Reuter, Rami Mahfouz, Roy Cambria, Nour Saheb, Christine S Ferrer, Shreya Vemuri, Marita Yaghi, Mariam Kanso, Abdul Abdullah, Ghina El Nounou, Mark Jabbour, Kerri Muenkel, Kristopher Kaufman, Joe-Max Wakim, Sandy Badson, Roger Wilson, Collette Houston, Marija Drobnjak, Jamal Hoballah, Fuad N Ziyadeh, Ghazi Zaatari, Murray Brennan, Eileen M O'Reilly, Ali K Abu-Alfa, Ghassan K Abou-Alfa
PURPOSE: Biobanking helps source tissue and blood for studying cancer genomics. Access to biorepository resources in low- and middle-income countries is lacking. Memorial Sloan Kettering Cancer Center (MSK) and the American University of Beirut (AUB) established a joint tissue biorepository at AUB in Beirut, Lebanon. The undertaking encountered key challenges that were unanticipated. MATERIALS AND METHODS: Patients age 18 years or older were eligible for enrollment at AUB...
September 2023: JCO global oncology
https://read.qxmd.com/read/37878356/biospecimen-qualification-in-a-clinical-biobank-of-urological-diseases
#69
JOURNAL ARTICLE
Olga Kofanova, Sangita Paul, Achilleas Pexaras, Camille Bellora, Ala Petersons, Margaux Schmitt, Mohamad Baker Berjaoui, Yazan Qaoud, Miran Kenk, Heidi Wagner, Neil Fleshner, Fay Betsou
Development of novel biomarkers for diagnosis of disease and assessment of treatment efficacy utilizes a wide range of biospecimens for discovery research. The fitness of biospecimens for the purpose of biomarker development depends on the clinical characteristics of the donor and on a number of critical and potentially uncontrolled pre-analytical variables. Pre-analytical factors influence the reliability of the biomarkers to be analyzed and can seriously impact analytic outcomes. Sample quality stratification assays and tools can be utilized by biorepositories to minimize bias resulting from samples' inconsistent quality...
October 25, 2023: Biopreservation and Biobanking
https://read.qxmd.com/read/37847820/efficacy-and-safety-of-anti-tumor-necrosis-factor-alpha-in-very-early-onset-inflammatory-bowel-disease
#70
JOURNAL ARTICLE
Lauren V Collen, Vanessa Mitsialis, David Y Kim, Mairead Bresnahan, Jessica Yang, Margaret Tuthill, Abigail Combs, Jared Barends, Michael Field, Enju Liu, Richelle Bearup, Ibeawuchi Okoroafor, Christoph Klein, Aleixo M Muise, Athos Bousvaros, Jodie Ouahed, Scott B Snapper
BACKGROUND: Very early onset inflammatory bowel disease (VEOIBD) is defined as disease onset in patients younger than 6 years. Challenges in treatment of VEOIBD include lack of approved therapies and increased incidence of monogenic immunodeficiencies. We report on patterns of anti-TNF use, efficacy, and safety in a large cohort of patients with VEOIBD. METHODS: Very early onset inflammatory bowel disease patients receiving care at a single center were prospectively enrolled in a data registry and biorepository starting in 2012...
October 17, 2023: Inflammatory Bowel Diseases
https://read.qxmd.com/read/37833423/generation-of-quality-controled-sars-cov-2-variant-stocks
#71
REVIEW
Maren de Vries, Grace O Ciabattoni, Bruno A Rodriguez-Rodriguez, Keaton M Crosse, Dominick Papandrea, Marie I Samanovic, Dacia Dimartino, Christian Marier, Mark J Mulligan, Adriana Heguy, Ludovic Desvignes, Ralf Duerr, Meike Dittmann
One of the main challenges in the fight against coronavirus disease 2019 (COVID-19) stems from the ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into multiple variants. To address this hurdle, research groups around the world have independently developed protocols to isolate these variants from clinical samples. These isolates are then used in translational and basic research-for example, in vaccine development, drug screening or characterizing SARS-CoV-2 biology and pathogenesis...
October 13, 2023: Nature Protocols
https://read.qxmd.com/read/37819913/specimen-sharing-for-epidemic-preparedness-building-a-virtual-biorepository-system-from-local-governance-to-global-partnerships
#72
JOURNAL ARTICLE
Judith Giri, Laura Pezzi, Rodrigo Cachay, Rosa Margarita Gèlvez Ramirez, Adriana Tami, Sarah Bethencourt, Anyela Lozano, José Eduardo Gotuzzo Herencia, Julia Poje, Thomas Jaenisch, May Chu
We present a framework for a federated, virtual biorepository system (VBS) with locally collected and managed specimens, as a 'global public good' model based on principles of equitable access and benefit sharing. The VBS is intended to facilitate timely access to biological specimens and associated data for outbreak-prone infectious diseases to accelerate the development and evaluation of diagnostics, assess vaccine efficacy, and to support surveillance and research needs. The VBS is aimed to be aligned with the WHO BioHub and other specimen sharing efforts as a force multiplier to meet the needs of strengthening global tools for countering epidemics...
2023: PLOS Glob Public Health
https://read.qxmd.com/read/37814710/plasma-proteoglycan-4-a-novel-biomarker-for-acute-lung-injury-after-pediatric-cardiac-surgery
#73
JOURNAL ARTICLE
Ahmed Asfari, Erica A Doyle, Gregory D Jay, Natalia Aristizabal, Ananya Manchikalapati, A K M Fazlur Rahman, Kristal M Hock, Santiago Borasino, Namasivayam Ambalavanan, Tannin A Schmidt, Leslie A Rhodes
BACKGROUND: Identification of biological molecules related to post cardiopulmonary bypass (CPB) lung injury could help diagnose, predict and potentially impact patient's clinical course after cardiac surgery. Proteoglycan 4 (PRG4) initially identified as potential biomarker for patients with prolonged mechanical ventilation following CPB in a prior study. To further validate these findings, we sought to understand the association of lower plasma PRG4 with prolonged mechanical ventilation and worse lung compliance in a larger cohort of pediatric patients post CPB...
September 18, 2023: Translational Pediatrics
https://read.qxmd.com/read/37805537/genomic-architecture-of-autism-spectrum-disorder-in-qatar-the-baraka-qatar-study
#74
JOURNAL ARTICLE
Mona Abdi, Elbay Aliyev, Brett Trost, Muhammad Kohailan, Waleed Aamer, Najeeb Syed, Rulan Shaath, Geethanjali Devadoss Gandhi, Worrawat Engchuan, Jennifer Howe, Bhooma Thiruvahindrapuram, Melissa Geng, Joe Whitney, Amira Syed, Jyothi Lakshmi, Sura Hussein, Najwa Albashir, Amal Hussein, Ilaria Poggiolini, Saba F Elhag, Sasirekha Palaniswamy, Marios Kambouris, Maria de Fatima Janjua, Mohamed O El Tahir, Ahsan Nazeer, Durre Shahwar, Muhammad Waqar Azeem, Younes Mokrab, Nazim Abdel Aati, Ammira Akil, Stephen W Scherer, Madeeha Kamal, Khalid A Fakhro
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impaired social and communication skills, restricted interests, and repetitive behaviors. The prevalence of ASD among children in Qatar was recently estimated to be 1.1%, though the genetic architecture underlying ASD both in Qatar and the greater Middle East has been largely unexplored. Here, we describe the first genomic data release from the BARAKA-Qatar Study-a nationwide program building a broadly consented biorepository of individuals with ASD and their families available for sample and data sharing and multi-omics research...
October 7, 2023: Genome Medicine
https://read.qxmd.com/read/37794452/cognitive-decrements-in-1991-gulf-war-veterans-associations-with-gulf-war-illness-and-neurotoxicant-exposures-in-the-boston-biorepository-recruitment-and-integrative-network-bbrain-cohorts
#75
JOURNAL ARTICLE
D Keating, M Krengel, J Dugas, R Toomey, L Chao, L Steele, Lloyd P Janulewicz, T Heeren, E Quinn, N Klimas, K Sullivan
BACKGROUND: During deployment, veterans of the 1991 Gulf War (GW) were exposed to multiple war-related toxicants. Roughly a third of these veterans continue to exhibit neurotoxicant induced symptoms of Gulf War Illness (GWI), a multi-faceted condition that includes fatigue, pain and cognitive decrements. When studied empirically, both deployed veterans with exposures and those who meet the criteria for GWI are more likely to show deficits in the area of neuropsychological functioning...
October 4, 2023: Environmental Health
https://read.qxmd.com/read/37788265/analytical-validation-of-genopharm-a-clinical-genotyping-open-array-panel-of-46-pharmacogenes-inclusive-of-variants-unique-to-people-of-african-ancestry
#76
JOURNAL ARTICLE
Comfort Ropafadzo Kanji, Bianza Tinotenda Mbavha, Collen Masimirembwa, Roslyn Stella Thelingwani
Pharmacogenomic testing may be used to improve treatment outcomes and reduce the frequency of adverse drug reactions (ADRs). Population specific, targeted pharmacogenetics (PGx) panel-based testing methods enable sensitive, accurate and economical implementation of precision medicine. We evaluated the analytical performance of the GenoPharm® custom open array platform which evaluates 120 SNPs across 46 pharmacogenes. Using commercially available reference samples (Coriell Biorepository) and in-house extracted DNA, we assessed accuracy, precision, and linearity of GenoPharm®...
2023: PloS One
https://read.qxmd.com/read/37784683/spatially-resolved-whole-transcriptome-analysis-of-histologically-characterized-tissue-microarray-of-patient-matched-primary-and-recurrent-glioblastomas-to-identify-underlying-mechanisms-of-treatment-resistance
#77
JOURNAL ARTICLE
K J Lee, R Chkheidze, H Alrefai, C Margaroli, A Gaggar, T Nguyen, J C Anderson, R Bash, C R Miller, C D Willey
PURPOSE/OBJECTIVE(S): Glioblastoma multiforme (GBM) is a lethal CNS malignancy. Radiation therapy increases overall survival, but tumors often recur in high-radiation dose regions. Additionally, recent investigations have underscored the importance of intra-tumoral heterogeneity as a driver of GBM biology. The purpose of this investigation is to characterize transcriptome differences in primary and recurrent GBM patient clinical samples using a digital spatial profiling approach to better appreciate treatment resistance mechanisms...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/37784380/a-precision-medicine-navigator-can-mitigate-inequities-associated-with-utilization-of-genomic-tests-in-black-men-with-prostate-cancer
#78
JOURNAL ARTICLE
A J Allen, B Savla, C Datnow-Martinez, W Mendes, S C Kamran, S Ambs, C Eggleston, K Baker, J K Molitoris, M J Ferris, A N Patel, Z H Rana, D Kunaprayoon, J J Hong, E Davicioni, M V Mishra, S M Bentzen, W F Regine Jr, Y Kwok, M A L Vyfhuis
PURPOSE/OBJECTIVE(S): Black men with prostate cancer in the United States experience disproportionately worse clinical outcomes compared to other racial groups. Identifying more reliable prognosticators to address these inequities has thus been the subject of considerable research scrutiny. However, prognostic genomic tools and genomic biorepositories suffer from an even greater lack of racial diversity. Strategies to mitigate these amplifying developments in inequities are desperately needed...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/37771758/hypergraph-factorization-for-multi-tissue-gene-expression-imputation
#79
JOURNAL ARTICLE
Ramon Viñas, Chaitanya K Joshi, Dobrik Georgiev, Phillip Lin, Bianca Dumitrascu, Eric R Gamazon, Pietro Liò
Integrating gene expression across tissues and cell types is crucial for understanding the coordinated biological mechanisms that drive disease and characterise homeostasis. However, traditional multitissue integration methods cannot handle uncollected tissues or rely on genotype information, which is often unavailable and subject to privacy concerns. Here we present HYFA (Hypergraph Factorisation), a parameter-efficient graph representation learning approach for joint imputation of multi-tissue and cell-type gene expression...
July 2023: Nature Machine Intelligence
https://read.qxmd.com/read/37763157/revolutionizing-cancer-research-the-impact-of-artificial-intelligence-in-digital-biobanking
#80
REVIEW
Chiara Frascarelli, Giuseppina Bonizzi, Camilla Rosella Musico, Eltjona Mane, Cristina Cassi, Elena Guerini Rocco, Annarosa Farina, Aldo Scarpa, Rita Lawlor, Luca Reggiani Bonetti, Stefania Caramaschi, Albino Eccher, Stefano Marletta, Nicola Fusco
BACKGROUND: Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an organized and governed manner. Exploiting diverse datasets produced by the biobanks and the downstream research from various sources and integrating bioinformatics and "omics" data has proven instrumental in advancing research such as cancer research. Biobanks offer different types of biological samples matched with rich datasets comprising clinicopathologic information...
September 16, 2023: Journal of Personalized Medicine
keyword
keyword
106057
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.